Erasca, Inc.

NASDAQ:ERAS

Biotechnology

Healthcare
$13.76 -0.14%

-$0.02 today

Market cap
$4.83B
Beta
0.73
P/E (TTM)
-15.3
EPS (TTM)
-$0.91
52W Low $1.21High $24.28

Volume 8.94M

Average 6.79M

Balance Sheet

Inspect the capital base behind the business.

Assets

$396.15M

FY 2025 · Annual

-21.2% YoY

Liabilities

$70.98M

FY 2025 · Annual

-10.2% YoY

Equity

$325.17M

FY 2025 · Annual

-23.2% YoY

Balance Sheet

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Cash & Equivalents360.49M284.22M93.08M67.74M73.81M
Short-term Investments53.99M151.4M219.28M230.57M202.27M
Net Receivables0002.3M2.5M
Inventory00000
Other Current Assets100K748K1.1M8.18M7.66M
Total Current Assets420.02M444.5M320.68M308.79M286.24M
Property, Plant & Equipment (Net)33.31M65.23M60.19M48.54M42.33M
Goodwill00000
Intangible Assets00000
Long-term Investments44.77M2M10.05M142.16M66.13M
Tax Assets00000
Other Non-current Assets3.32M3.18M4.38M3.03M1.45M
Total Non-current Assets81.4M70.41M74.62M193.73M109.92M
Total Assets501.42M514.91M395.3M502.53M396.15M
Account Payables4.68M23.05M2M468K981K
Short-term Debt00000
Tax Payables00000
Deferred Revenue00000
Other Current Liabilities4.16M2.33M10.78M10.65M12.07M
Total Current Liabilities26.22M48.69M26.16M31.4M28.51M
Long-term Debt00000
Deferred Tax Liabilities00000
Deferred Revenue (Non-current)00000
Other Non-current Liabilities158K573K566K362K399K
Total Non-current Liabilities18.66M54.37M52.46M47.63M42.47M
Total Liabilities44.89M103.06M78.61M79.03M70.98M
Common Stock12K15K15K28K28K
Retained Earnings(238.17M)(480.97M)(606.01M)(767.66M)(892.21M)
Accumulated OCI(162K)(1.04M)77K405K628K
Other Stockholders Equity0(0)000
Minority Interest00000
Total Equity456.53M411.85M316.69M423.5M325.17M
Total Debt18.79M55.1M55.86M51.89M47.14M
Net Debt(341.7M)(229.12M)(37.22M)(15.85M)(26.67M)

Balance Sheet

Assets, liabilities & equity

Cash & Equivalents$119.0M
Short-term Investments$524.7M
Other Current$11.5M
Total Current Assets$655.2M
PP&E (Net)$38.0M
Long-term Investments$304.1M
Other Non-current$1.6M
Total Non-current Assets$343.7M
Total Assets$998.9M

Analysis

Selected assets total $998.9M for Latest. The largest visible component is Short-term Investments at $524.7M, about 52.5% of the tab total. Use the mix to judge balance sheet concentration, liquidity, leverage, and how much of book value is supported by tangible operating assets.

Recent Filings

Recent regulatory filings

FilingDescriptionDate
10-QQuarterly reportNov 12, 2026
8-KCurrent reportNov 12, 2026
8-KCurrent reportOct 16, 2026
8-KCurrent reportAug 24, 2026
SC 13G/ASC 13G/A filingAug 14, 2026

How much cash does ERAS have?

Erasca, Inc. (ERAS) reported $73.81M in cash and equivalents in fiscal 2025.

How much debt does ERAS carry?

Erasca, Inc. (ERAS) reported $47.14M of total debt, with net debt of -$26.67M.